These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39002799)

  • 1. Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends.
    Biscaia-Caleiras M; Fonseca NA; Lourenço AS; Moreira JN; Simões S
    J Control Release; 2024 Sep; 373():617-639. PubMed ID: 39002799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
    Amasya G; Aksu B; Badilli U; Onay-Besikci A; Tarimci N
    Int J Pharm; 2019 May; 563():110-121. PubMed ID: 30935913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review.
    Cunha S; Costa CP; Moreira JN; Sousa Lobo JM; Silva AC
    Nanomedicine; 2020 Aug; 28():102206. PubMed ID: 32334097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product Development, Manufacturing, and Packaging of Solid Dosage Forms Under QbD and PAT Paradigm: DOE Case Studies for Industrial Applications.
    Singh BN
    AAPS PharmSciTech; 2019 Sep; 20(8):313. PubMed ID: 31529232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Astonishing Accomplishment of Biological Drug Delivery using Lipid Nanoparticles: An Ubiquitous Review.
    Kapoor D; Chilkapalli SC; Prajapati BG; Rodriques P; Patel R; Singh S; Bhattacharya S
    Curr Pharm Biotechnol; 2024; 25(15):1952-1968. PubMed ID: 38265380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Continuous Manufacturing of Topical Semisolids by Hot Melt Extrusion Soon Be a Reality?
    Matadh AV; Echanur A; Suresh S; Chede L; Maibach H; Kulkarni V; Murthy SN; H N S
    Mol Pharm; 2023 Aug; 20(8):3779-3790. PubMed ID: 37421361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by design and process analytical technology for sterile products--where are we now?
    Riley BS; Li X
    AAPS PharmSciTech; 2011 Mar; 12(1):114-8. PubMed ID: 21181513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by Design in Pharmaceuticals: A Review of its Impact on Regulatory Compliance and Product Quality.
    Nunavath RS; Singh MT; Jain A; Chakma M; Arivuselvam R; Azeeze MSTA
    Drug Res (Stuttg); 2024 Jan; 74(1):18-23. PubMed ID: 38134919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization techniques for lipid based delivery systems for siRNA.
    Kapoor M; Burgess DJ; Patil SD
    Int J Pharm; 2012 May; 427(1):35-57. PubMed ID: 21979250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach.
    Waghule T; Dabholkar N; Gorantla S; Rapalli VK; Saha RN; Singhvi G
    Biomed Pharmacother; 2021 Sep; 141():111940. PubMed ID: 34328089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview on recent patents and technologies on nanoparticles for nucleic acid delivery.
    Dos Santos Fonseca LM; Machado BAS; Oliveira FO; de Jesus Santos JR; da Silva JW; Hodel KVS; Rosatti BG; Pinto CD; Soares MBP
    Expert Opin Ther Pat; 2024 Mar; 34(3):171-186. PubMed ID: 38578253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules.
    Gonella A; Grizot S; Liu F; López Noriega A; Richard J
    Expert Opin Drug Deliv; 2022 Aug; 19(8):927-944. PubMed ID: 35899474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems.
    Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
    Pharm Res; 2018 Nov; 36(1):4. PubMed ID: 30406349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook.
    Wang S; Wang H; Drabek A; Smith WS; Liang F; Huang ZR
    Mol Pharm; 2024 Jan; 21(1):4-17. PubMed ID: 38117251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization.
    Carbone C; Cupri S; Leonardi A; Puglisi G; Pignatello R
    Pharm Pat Anal; 2013 Sep; 2(5):665-77. PubMed ID: 24237173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the gaps between academic research and industrial product developments of lipid-based formulations.
    Holm R
    Adv Drug Deliv Rev; 2019 Mar; 142():118-127. PubMed ID: 30682399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing lipid nanoparticles for topical ocular drug delivery.
    Alvarez-Trabado J; Diebold Y; Sanchez A
    Int J Pharm; 2017 Oct; 532(1):204-217. PubMed ID: 28893582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.